Aculeus Therapeutics
PrivateLast Round
SAFE
Sep 1, 2023
Total Funding Raised
$1.46M
Company Overview
Aculeus Therapeutics operates in Healthcare & Life Sciences and is based in Parkville. Its latest recorded funding round was a SAFE round in September 2023.
Aculeus Therapeutics is a biotechnology company that develops small molecule drugs that modulate the immune system for the treatment of cancer and other serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aculeus Therapeutics Comparables
Compare Aculeus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmuneSensor Therapeutics | 83% | |
| TXINNO Bioscience INC | 81% | |
| Stingray Therapeutics | 81% |
For institutional investors. Book with your work email.
Aculeus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Sep 1, 2023 | ||||
| Grant | Jul 23, 2021 | ||||
| Grant | Nov 9, 2020 |
For institutional investors. Book with your work email.
Aculeus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Therapeutic Innovation Australia | Grant |
| SYNthesis BioVentures | SAFE |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2023
$1.46M round led by SYNthesis BioVentures
- Jul 23, 2021
Received grant funding from Therapeutic Innovation Australia.
For institutional investors. Book with your work email.
Aculeus Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aculeus Therapeutics's valuation, stock price, and market status.
Is Aculeus Therapeutics a public or private company?
Aculeus Therapeutics is a private company.
What is the current stock price of Aculeus Therapeutics?
Aculeus Therapeutics is a private company, so its shares have no public market price. Caplight tracks Aculeus Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aculeus Therapeutics worth (valuation)?
Valuation information for Aculeus Therapeutics is not publicly available.
Can I buy Aculeus Therapeutics stock?
Aculeus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aculeus Therapeutics's last funding round?
Aculeus Therapeutics's most recent funding round was SAFE on September 1, 2023.
Who are the main investors in Aculeus Therapeutics?
Key investors in Aculeus Therapeutics include SYNthesis BioVentures.
Will Aculeus Therapeutics IPO soon?
No public IPO plans have been announced for Aculeus Therapeutics.
How can I track Aculeus Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Aculeus Therapeutics's shares on secondary markets.